PD
Pro-Dex, Inc.
PDEX · NASDAQ
$72.55 +2.97% (+$2.09)
1M +8.51%
Market Cap $231.6M
P/E Ratio 16.95x
Div. Yield -
ROE 31.05%
Bulios Fair Price
$94.88
30.8% upside
Current Price
$72.55
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PDEX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
51 /100
Fair P/FCF 33.61x
P/E 16.95x
P/B 4.86x
Growth
96 /100
Growing FCF growth 17.29%
EPS growth 28.32%
Book val. growth 14.67%
Profitability
70 /100
Strong Op. margin 16.75%
Gross margin 31.38%
FCF margin 8.89%
Quality
98 /100
Excellent ROA 18.34%
ROIC 24.54%
Asset turnover 1.04x
Debt
94 /100
Low Int. coverage 11.10x
Debt/Equity 0.38x
Net debt/EBITDA 0.76x
Stability
45 /100
Moderate EPS volatility 212.66%
Beta 0.06x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PDEX
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Richard Lee Van Kirk Jr.
Employees
201
Headquarters
Irvine
Upcoming events
29 OCT
Earnings
Upcoming earnings report